Dr. Navin Kapur

Dr. David A. Morrow is the director of the Cardiac Intensive Care Unit (CICU) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also a professor of medicine at Harvard Medical School (HMS). He received his medical degree from HMS. He completed an internal medicine residency and a cardiology fellowship at BWH. He is board certified in internal medicine and cardiovascular disease. Dr. Morrow’s clinical interests include cardiac intensive care and ischemic heart disease. At the CICU, he designed and implemented a new multidisciplinary program—the BWH Acute Aortic Syndrome Program and the Shock Team—that helps streamline and improve aortic care and shock management. Dr. Morrow’s research centers on clinical management strategies and novel therapeutics for ischemic heart disease. This includes both stable and unstable ischemic syndromes, with a related focus on the use of cardiovascular biomarkers for risk stratification and clinical decision-making. The author of over 200 peer-reviewed publications, he has received research funding from the National Institutes of Health. Castle Connolly has listed him as one of America’s Top Doctors. Dr. Morrow is rated as an Elite provider by MediFind in the treatment of Heart Attack. His top areas of expertise are Cardiogenic Shock, Heart Attack, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Robert Yeh is a Cardiologist and an Internal Medicine provider in Boston, Massachusetts. Dr. Yeh is rated as an Elite provider by MediFind in the treatment of Heart Attack. His top areas of expertise are Heart Attack, Coronary Heart Disease, Angina, Percutaneous Coronary Intervention (PCI), and Stent Placement.

Dr. Marc S. Sabatine is chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group at Brigham and Women’s Hospital (BWH) and holds the Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine. A cardiovascular specialist, he is also a professor of medicine at Harvard Medical School (HMS).Dr. Sabatine received his medical degree from HMS and completed a residency in internal medicine at Massachusetts General Hospital (MGH). He then completed a clinical fellowship in cardiovascular disease at Massachusetts General Hospital and a fellowship in cardiovascular research at BWH. Dr. Sabatine is board certified in internal medicine and cardiovascular disease and is a fellow of the American Heart Association, the American College of Cardiology and the European Society of Cardiology.His clinical interest is in acute coronary syndromes and critical care, and he attends in the Cardiac Intensive Care Units at both BWH and MGH. His research interests include coronary artery disease, acute coronary syndromes, dyslipidemias, proteomics and genomics. As the chairman of the TIMI Study Group—an academic research organization that has led major cardiovascular medicine clinical trials since its inception in 1984—Dr. Sabatine leads large-scale international randomized controlled trials testing novel therapies for cardiovascular care that have shaped the practice of medicine.Dr. Sabatine has authored over 200 peer-reviewed publications, is on the writing committees for practice guidelines, and has received research funding from the American College of Cardiology and the National Institutes of Health. Dr. Sabatine is rated as a Distinguished provider by MediFind in the treatment of Heart Attack. His top areas of expertise are Heart Attack, Heart Failure, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).